RMD

ResMed Inc.

Healthcare
186.46 +3.64 +1.99% Market Closed
2026-06-03 • USD

Key Metrics

Market Cap 27.05B
EV —
Shares Out 145.06M
Revenue (ttm) —
Net Income 1.53B
Beta —
P/E 17.68
Forward P/E —
EPS (ttm) $10.52
P/S —
P/B 4.17
P/FCF —
P/C —
EV/Sales —
EV/EBITDA —
ROA 18.07%
ROE 24.6%
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Debt/Eq 0.13
LT Debt/Eq 5.86%
Quick Ratio —
Current Ratio 3.01
Book/sh 44.67
Cash/sh 11.43
Div Yield 1.29%
Div TTM $2.40
Payout Ratio 22.81%
SMA20 -7.58%
SMA50 -12.88%
SMA200 -24.67%
Volume 1,683,956
Avg Volume 1.27M
Rel Volume —
Perf Week -2.16%
Perf Month -10.30%
Perf Quarter -26.97%
Perf Half Y -27.32%
Perf YTD -22.59%
Perf Year -25.32%
Perf 3Y -16.05%
Perf 5Y -9.18%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $0.6000
TTM Yield 1.29%
TTM Amount $2.40
Payout Ratio 22.81%
3-Yr Growth (CAGR) 1.93%
5-Yr Growth (CAGR) 8.35%

Last 12 Payouts

Period Ex-Date Amount / Share
Q3 2026 2026-05-13 $0.6000
Q2 2025 2026-02-11 $0.6000
Q1 2025 2025-11-12 $0.6000
Q1 2025 2025-08-13 $0.6000
Q3 2025 2025-05-07 $0.5300
Q4 2024 ~2025-04-01 $0.5800
Q2 2024 2025-02-12 $0.5300
Q1 2024 2024-11-06 $0.5300
Q1 2024 2024-08-14 $0.5300
Q3 2024 2024-05-08 $0.4800
Q4 2023 ~2024-03-31 $0.5200
Q2 2023 2024-02-07 $0.4800

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

ResMed Inc. is a global leader in digital health and cloud-connected medical devices. The company designs innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. ResMed's digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease (COPD), and other chronic diseases. The company's Sleep and Breathing Health segment offers continuous positive airway pressure (CPAP) systems, bilevel air devices, high-flow therapy devices, non-invasive and invasive ventilators, masks, and data management systems. The Residential Care Software segment provides cloud-based solutions to healthcare providers in durable/home medical equipment, home infusion, home health, hospice, skilled nursing facilities, senior living, and life plan communities. The company employs more than 10,600 people and sells products in more than 140 countries through wholly owned subsidiaries and independent distributors. ResMed generates approximately $5.1 billion in annual revenue and invests 6-7% of revenue in research and development.

Name
ResMed Inc.
Industry
Medical Devices
CEO
Michael Farrell · Chairman of the Board and Chief Executive Officer
Employees
10,600 as of 2025-06-30
IPO Date
2018-05-04
Phone
(858) 836-5000
Address
9001 Spectrum Center Blvd., San Diego, CA 92123
Website
www.resmed.com

Key Executives

Name Title FY Pay
Ronald Taylor Lead Director —
Karen Drexler Director —
Carol Burt Director —
Peter Farrell Founder and Chairman Emeritus —
Michael Farrell Chairman of the Board and Chief Executive Officer —

Latest News